AtriCure (ATRC)
(Real Time Quote from BATS)
$21.07 USD
-0.98 (-4.44%)
Updated Aug 5, 2024 10:00 AM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ATRC 21.07 -0.98(-4.44%)
Will ATRC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ATRC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ATRC
AtriCure (ATRC) Reports Q2 Earnings: What Key Metrics Have to Say
AtriCure (ATRC) Reports Q2 Loss, Lags Revenue Estimates
ATRC: What are Zacks experts saying now?
Zacks Private Portfolio Services
AtriCure (ATRC) Gains China Approval for AtriClip LAA System
Abbott (ABT) Q2 Earnings and Revenues Top Estimates
Compared to Estimates, AtriCure (ATRC) Q1 Earnings: A Look at Key Metrics
Other News for ATRC
AtriCure Inc (ATRC) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
Atricure (ATRC) Gets a Buy from Oppenheimer
AtriCure price target lowered by $5 at BTIG, here's why
AtriCure price target lowered by $4 at Stifel, here's why
AtriCure’s Resilience Amidst Competition: A Strong Buy Recommendation